All Journal articles

Journal

May 2023 – Contents

May 2023   |   Volume 20   |   No.5

Journal

Evolution of GMO requirements for innovative investigational medicinal products upon transition to the EU CTR

2023-05-18T12:58:00Z

The EU CTR replaced the EU CTD on 31 January 2022, which impacts investigational medicinal products that fall under genetically modified organisms (GMO-IMPs).

Journal

G-E-T-ting there – how gene editing technologies could change more than genes

2023-05-18T12:57:00Z

The field of genome editing technologies (GETs) is rapidly advancing, marking a new and exciting era of curative medicines. These products can alter genetic material in patients, highlighting the crucial need to introduce dedicated legislation to ensure that GETs are developed and maintained in a safe and effective manner.

Journal

Alternatives to animal testing
in the development of ATMPs

2023-05-18T12:56:00Z

This article looks at a range of innovative non-animal test methods, including in vitro tests based on human and animal cells, genomic technologies and in silico modelling.

Journal

Regulatory guidelines for
nutraceuticals in India

2023-05-18T12:55:00Z

The regulatory landscape for nutraceuticals in India, and the required approval processes for market

Journal

Ensuring promotional
materials’ compliance
in the EU

2023-05-18T12:55:00Z

Directive 2001/83/EC is the EU legislation specifically covering promotional materials for the pharmaceutical industry – notably, Title VIII Advertising and Title VIIIa Information and Advertising. This is in addition to general consumer protection laws and unfair commercial practices regulations and directives. While Directives are legally binding and directly applicable to all companies. Some granularities can be introduced when it is transposed into national legislation by Member States (MS) individual legislatures.

Journal

Does sole dependence on reliance models contribute to a sustainable healthcare ecosystem?

2023-04-06T08:00:00Z

Governments should strive for a sustainable and global regulatory framework adept to deal with a healthcare crisis and similar issues that may arise in the future. This article looks at regulatory frameworks in international regions through AstraZeneca’s experience with the Vaxzevria^TM vaccine.

Journal

The transition period of the new API framework in Brazil is coming to an end

2023-04-06T07:57:00Z

The new active pharmaceutical ingredients regulatory framework in Brazil begins August 2023

Journal

Registration and post-approval variation of pharmaceutical drugs in Latin America:
challenges and opportunities

2023-04-06T07:57:00Z

This article provides an overview of the critical challenges for pharmaceutical drug registration and post-approval changes for manufacturers in six major Latin American countries.

Journal

Contraceptive product registration:
regional harmonisation through the East African Community mechanism

2023-04-06T07:57:00Z

The COVID-19 pandemic disrupted access to contraception as a result of supply chain challenges, staff shortages and lockdowns, to name a few. This article looks at Catalyst Global’s experience in registering the contraceptive product, AVIBELA, using the East African Community Medicines Regulatory Harmonisation Initiative.

Journal

An overview of the regulatory framework for advanced therapies

2023-04-06T07:57:00Z

Advanced therapy medicinal products (ATMPs) have recently advanced in development and are subject to regulation in some markets. This article summarises the regulatory framework for ATMPs in some of the markets where these requirements are in place: Argentina, Brazil, Europe, and the US.

Journal

April 2023

Journal

March 2023

Journal

Direct healthcare professional communication as an intervention tool – retrospective analysis

2023-03-07T15:44:00Z

The direct healthcare professional communication (DHPC) is a communication intervention by which important safety information is delivered directly to individual healthcare professionals (HCPs), alerting them to take certain actions to ensure the safe and effective use of medicines.

Journal

Is consulting in regulatory affairs your next career path?

2023-03-07T13:38:00Z

Navigating the corporate ladder isn’t always clear cut. Along the way you may move in and out of the industry, stay in one position for too long, or even jump from specialist to director. Some ditch the politics all together and become their own boss. What is it like being a consultant, contingent worker, or contractor?

Journal

EMA’s IDMP-SPOR Implementation Guideline v2.1.1

2023-03-07T13:36:00Z

Identification of Medicinal Products (IDMP) standards were developed by the ISO to specify the use of standardised definitions for the identification and description of medicinal products for human use. In this article, we provide an overview of the latest IDMP v2.1.1 guideline and summarise that – given the scope of changes – it is relatively low impact to the regulatory profession.

Journal

Environmental impact of pharmaceuticals and regulation in the EU

2023-03-07T13:32:00Z

The profound impact of pharmaceuticals on the environment has been acknowledged for decades. In the EU, two key mechanisms that assess this risk are the Environmental Risk Assessment (ERA), and Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). As both frameworks are under assessment, this article looks at the key considerations within the ERA.

Journal

IMDRF: Origins, purpose and current work

2023-03-07T13:29:00Z

In a landscape of rapidly evolving technologies, the International Medical Device Regulatory Forum (IMDRF) aims to accelerate international medical device harmonisation. A summary of the work being undertaken by the IMDRF

Journal

February 2023

Journal

Accelerated regulatory pathways: Vaccines for tropical diseases

2023-02-07T11:36:00Z

Reproduced from an online seminar presentation, made in collaboration with TOPRA and hVIVO, given on 21 June 2022 by Bruno Speder from hVIVO.